BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 16877121)

  • 1. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.
    Gold SM; Irwin MR
    Neurol Clin; 2006 Aug; 24(3):507-19. PubMed ID: 16877121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines as mediators of depression: what can we learn from animal studies?
    Dunn AJ; Swiergiel AH; de Beaurepaire R
    Neurosci Biobehav Rev; 2005; 29(4-5):891-909. PubMed ID: 15885777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-immune communication psychoneuroimmunology of multiple sclerosis.
    Kern S; Ziemssen T
    Mult Scler; 2008 Jan; 14(1):6-21. PubMed ID: 17881389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta-endorphin in the pathophysiology of major depression.
    Hegadoren KM; O'Donnell T; Lanius R; Coupland NJ; Lacaze-Masmonteil N
    Neuropeptides; 2009 Oct; 43(5):341-53. PubMed ID: 19647870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune activation and depression in the elderly].
    Maas DW; Westendorp RG; van der Mast RC
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1413-7. PubMed ID: 18624003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress and disease progression in multiple sclerosis and its animal models.
    Gold SM; Heesen C
    Neuroimmunomodulation; 2006; 13(5-6):318-26. PubMed ID: 17709954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
    Pucak ML; Kaplin AI
    Int Rev Psychiatry; 2005 Dec; 17(6):477-83. PubMed ID: 16401546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-informed assessment and treatment of depression in HCV and interferon-treated patients.
    Angelino AF; Treisman GJ
    Int Rev Psychiatry; 2005 Dec; 17(6):471-6. PubMed ID: 16401545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of cytokines in depression].
    Dubas-Slemp H; Marmurowska-Michałowska H; Szuster-Ciesielska A; Kamińska T; Kandefer-Szerszeń M
    Psychiatr Pol; 2003; 37(5):787-98. PubMed ID: 14631599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of fatigue in multiple sclerosis: review of the literature.
    Kos D; Kerckhofs E; Nagels G; D'hooghe MB; Ilsbroukx S
    Neurorehabil Neural Repair; 2008; 22(1):91-100. PubMed ID: 17409388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress and depression-induced immune dysfunction: implications for the development and progression of cancer.
    Reiche EM; Morimoto HK; Nunes SM
    Int Rev Psychiatry; 2005 Dec; 17(6):515-27. PubMed ID: 16401550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression.
    Kemeny ME; Schedlowski M
    Brain Behav Immun; 2007 Nov; 21(8):1009-18. PubMed ID: 17889502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice selected for high versus low stress reactivity: a new animal model for affective disorders.
    Touma C; Bunck M; Glasl L; Nussbaumer M; Palme R; Stein H; Wolferstätter M; Zeh R; Zimbelmann M; Holsboer F; Landgraf R
    Psychoneuroendocrinology; 2008 Jul; 33(6):839-62. PubMed ID: 18502051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive disorders and immunity: 20 years of progress and discovery.
    Irwin MR; Miller AH
    Brain Behav Immun; 2007 May; 21(4):374-83. PubMed ID: 17360153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.
    Pucak ML; Carroll KA; Kerr DA; Kaplin AI
    Dialogues Clin Neurosci; 2007; 9(2):125-39. PubMed ID: 17726912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding fatigue in major depressive disorder and other medical disorders.
    Arnold LM
    Psychosomatics; 2008; 49(3):185-90. PubMed ID: 18448771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indicators of the persistent pro-inflammatory activation of the immune system in depression].
    Cubała WJ; Godlewska B; Trzonkowski P; Landowski J
    Psychiatr Pol; 2006; 40(3):431-44. PubMed ID: 17037810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory markers in depression.
    Dinan TG
    Curr Opin Psychiatry; 2009 Jan; 22(1):32-6. PubMed ID: 19122532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines: abnormalities in major depression and implications for pharmacological treatment.
    O'Brien SM; Scott LV; Dinan TG
    Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N; Schwarz MJ
    Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.